Development of epigenome therapeutic agents and treatments to improve cognitive impairments in schizophrenia

Mayu Fukuda, Joseph A. Gogos, Jun Mukai

[4P-286] Development of epigenome therapeutic agents and treatments to improve cognitive impairments in schizophrenia

〇Mayu Fukuda¹, Joseph A. Gogos², Jun Mukai¹ (1.Univ of Tsukuba, Ibaraki, Japan, 2.Columbia Univ, NewYork, USA)

Keywords:WORKING MEMORY, Setd1a, Schizophrenia

Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.

https://membership.jnss.org/C00/login

Presentation information

[4P] Working Memory

[4P-286] Development of epigenome therapeutic agents and treatments to improve cognitive impairments in schizophrenia

Password